ADA Report. New Era of Type 2 Diabetes Treatment after EMPA, LEADER etc juni 11, 2017 2:53 e m Läs mer »
ADA Report. Sulfonylureas in T2DM, low cost but risks for hypoglycemia and weight increase. New better drugs coming in juni 11, 2017 2:46 e m Läs mer »
ADA Report. New SUSTAIN-6 Data Could Explain Retinopathy Worsening in T2DM juni 10, 2017 11:18 e m Läs mer »
ADA Report. New SUSTAIN-6 Data Could Explain Retinopathy Worsening in T2DM juni 10, 2017 11:13 e m Läs mer »
SGLT2 Inhibitors Double the Risk for Diabetic Ketoacidosis. N Engl J Med juni 10, 2017 4:40 e m Läs mer »
ADA Report. Shared Decision-Making—Strategies for Improvements in Patient-Provider Communication juni 10, 2017 3:56 e m Läs mer »
ADA Report. Investigators are developing new approaches to modulate beta-cell function juni 10, 2017 3:47 e m Läs mer »
ADA Report. Novel diabetes medications may affect heart failure outcomes in T2DM juni 10, 2017 3:44 e m Läs mer »
